The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Already well up!
looks like a good rise ... and i wish you all the best .... Just be aware Manufaxcturing is my area 80mill over 10 years do the maths... standard profit margin in manufacturing is around 10% ) not sure on Aerospace 20% max, RR even has a fund to bail out its suppliers just another view point and wish you all the best and looking good so far :)
30% today Harold?
Got in too but only with NT trade! This will move today imho! Massive contract with RR £80m and MCAP 26m!
5k!
http://www.investegate.co.uk/avingtrans-plc-(avg)/prn/contract-with-rollsroyce/20121128070000P5262/
Valued at £80m...huge contract should see a big rise today surely this is massive for avg!
Now can't buy at all....unusual over 1pm-2pm period. Sell now at 89p
Max buy £1500 at full ask
£13.5m sale of Jena Tec division....sounds good for a Company with an overall MCap of 23m. 'The proceeds of the Sale will be used to invest further in the growth of these (Aerospace and Energy & Medical) divisions and to reduce debt, whilst the Board also continues to evaluate acquisition targets that it believes will enhance long-term shareholder value'. Only 26m shares in issue and order book in Aerospace division at record levels. Looks very promising....
Valuation: A play on globalising supply chains We continue to view Avingtrans as a long-term growth play allowing access to the globalisation of supply chains in structural growth markets. We believe the current rating of 10.7x CY12 EPS, falling to 9.0x CY13 EPS, does not yet fully recognise this potential, or the impact the strategy has had in securing long-term value creation. Our sum-of-the-parts valuation on to a CY13 basis yields a fair value of 146p per share
Roger McDowell, Chairman, said: "For the second year in succession, I am pleased to report that group revenue and adjusted earnings before interest, tax, depreciation and amortisation (EBITDA) have grown by over 20%. Indeed, adjusted EBITDA margin is a respectable 9.5%, with adjusted earnings per share having more than doubled in the past two years, whilst net debt remains at manageable levels. "All of these results were in line with market expectations, so our consistent form continues. While the board is encouraged by this improved performance, prediction is very difficult, especially about the future ... so we remain cognisant of the volatile nature of global markets. Some elements of our key markets remain in a state of flux and we have seen this across our group with improvements in Aerospace being offset by stubborn weakness in Energy and Medical. Whilst we remain optimistic, this sentiment is tempered, to ensure that we sustain the shareholder value gains of the last two years." The firm opted to increase the final dividend from 0.4p to 1.0p year-on-year. Net debt increased to £8.4m (2011: £6.6m), £0.7m of which was due to the Sigma Composites acquisition made earlier in the year.
Avingtrans, which designs, manufactures and supplies critical components and associated services to the global aerospace, energy, medical and industrial sectors, has boosted its full year turnover by a fifth. Revenue increased 21% to a record £44.0m (2011: £36.3m), although the gross profit margin fell two percentage points to 27% on it described as an "adverse product mix" and increased sales costs to £31.96m (2011: £25.61m). Pre-tax profit consequently fell from £1.42m to £1.24m, with basic earnings per share declining from 4.9p to 3.6p. More positively, the order book is currently at a record level. The Sigma business grew 52% during the year, its best year so far, having experienced strong growth in the civil aerospace market, while the C&H business continued to grow positively and strengthened its position with Rolls Royce. Metalcraft improved in the second half, with overall revenue growth in the division of 16%, while Crown downsized to limit future losses, resulting in a £0.85m impairment to goodwill. The Jena Tec business sustained its strong growth curve, 12% overall, notably in Germany and the US, to record a consistent 11% earnings before interest and tax margin.
Valuation: Attractive opportunity remains Given the positive trading update and ongoing progress the group is making, we continue to believe that Avingtrans remains an attractive proposition to gain access to global growth drivers. We are maintaining our forecasts and our sum-of-the-parts fair value moves to 120p/share as a result of updated peer valuations.
The performance of the Energy and Medical division has been held back by delays to the next generation MRI systems being developed by Siemens and, specifically in relation to the group's Crown business, on-going market weakness in the transport infrastructure sector. The firm was keen to emphasise that the Siemens programme is progressing, albeit slower than anticipated and Crown is awaiting final confirmation of a new £200k contract for CCTV infrastructure on the M4/M5 Managed Motorway programme. In response to market weakness, Avingtrans has taken measures at Crown to manage costs to an absolute minimum. Beyond these, the flow of work for the division from other key customers has been "satisfactory" and new project wins are in line with forecasts. "Although market conditions continue to be challenging, buoyed by positive trends in the Aerospace sector, we remain confident overall in continuing to perform in line with market expectations," the firm said in a statement.
Avingtrans, a manufacturer of critical components and associated services to the medical, energy, industrial and global aerospace sectors, has reported that group sales for the year ended May 31st are expected to be 20 per cent ahead of the previous year, in line with market expectations, following growth in all divisions. The company highlighted the overall improved performance in its Aerospace division. It is continuing to invest in the recently formed Sigma Composites business. While sales at Sigma Composites have been lower than expected, Avingtrans still reckons that the unit will contribute strongly to the Aerospace division in the future. The company is in final negotiations with the European Union to participate in its "Clean Sky" programme to develop new technology for more environmentally sustainable aircraft, rotorcraft and propulsion systems. The Industrial business experienced a solid year with strong results in Germany and the US. Recently, Jena Tec's automation division, Moss Group, received orders worth around £0.6m.
Avingtrans reinstalls dividend Date: Wednesday 14 Sep 2011 LONDON (ShareCast) - Avingtrans, designer, manufacturer and supplier of critical components and associated services to the energy, medical, industrial and global aerospace sectors, posted a 32% increase in full year earnings and reintroduced a dividend payment.
Commenting on the results, Roger McDowell, Chairman, said: "Whilst 2011 was not a `vintage year', I'm sure that shareholders will join me in a small toast to a much improved performance in the last 12 months. I am glad to report a result in line with previously upgraded market expectations. After an arduous financial year in 2010, the majority of our markets continued to regenerate positively. Global recovery has certainly played its part, but above all it is our hard work on capability enhancements over the last two years that has paid off. Long term contracts with global OEMs that are not dependent on the UK economy are very important to our future and potential further good news is in the pipeline. As anticipated at the half year, we are pleased to confirm a return to our progressive dividend policy, with our commitment to pay a final dividend in line with expectations and a firm intention to continue with dividend payments in future."
Final Results for the Year Ended 31 May 2011 Avingtrans plc, which designs, manufactures and supplies critical components and associated services to the medical, energy, industrial and global aerospace sectors, today announces its results for the twelve months ended 31 May 2011. Financial Highlights - Turnover increased by 27% to £36.3m (2010: £28.6m) - Gross profit margin increased to 29% (2010: 26%) - EBITDA improved by 32% to £3.3m (2010: £2.5m) - PBT1 increased to £1.4m (2010: £0.5m) - Fully diluted, adjusted1 EPS of 5.5 pence per share (2010: 3.0 pence per share) - Cash generated from operations was £3.0m (2010: £3.8m) - Net debt reduced by 15% to £6.6m (2010: £7.8m) - Gearing reduced further to 29% (2010: 36%) - Final Dividend reintroduced at 0.4 pence (2010: Nil)
http://www.investegate.co.uk/Article.aspx?id=20110914070000P8200
Nice rise here may it long may it continue long term hold in my portfolio. Lot of buying in the markets in the last few days good to see some of it directed here.
Avingtrans (LON:AVG) , the AIM listed manufacturing group, drove up sales by 25% to £16.9m in the six months to last November. The performance reinforced news from the company last month that it was on course to beat financial expectations this year. Avingtrans makes and supplies critical components and services for the medical, energy, industrial and global aerospace sectors. It credited the latest figures to a strong flow of new contracts with global original equipment manufacturers (OEMs) that are not dependent on the UK economy. The Avingtrans share price was up just short of 1% at 57.5p during the morning. Gross profit margins during the first half of the year increased to 28.8% from 22.6% in the same period last year. Ebitda improved by 50% to £1.5m and gearing was down further to 34% - or £7.5m - from 36% in 2010. Pre-tax profits came in at £0.5m against a small loss in the first half of 2010 and against a £0.47m profit for the whole of 2010. The company said it was now anticipating being able to reinstate a final dividend for the full year. Among the highlights during the period, Avingtrans’ Sigma China division, which manufacturers components for the aerospace industry, broke into profit. That was helped by the bedding in of long-term contracts with the likes of ITA, Eaton and Meggitt. Elsewhere, positive performances were put in by the group’s CH Precision Finishers, Stainless Metalcraft and Crown International divisions. Likewise, Jena Tec, which makes precision components, experienced strong first half demand in global orders and, post-period, won its largest single contract to date - worth £1.8m over three years. Roger McDowell, the chairman of Avingtrans, said: “After an arduous period in the previous financial year, it is pleasing to report on an encouraging first half. Building on the improving position in the second half of last year, we have seen the majority of our markets regenerate positively. Improvements are down in part to global recovery, but also down to the hard work completed within our divisions on capability enhancements over the last 18 months. Recovery has been further assisted by long term contracts with global OEMs that are not dependent on the UK economy. Continued new contract wins support our faith in the group’s long term strategy and underline the reasons why the Board indicated to the market on 17 January 2011 that it expects to exceed previous expectations. Consequentially, we have also concluded that we can commit to a recommencement of the payment of a dividend with the final results this year. I am sure investors will join me in welcoming this news.”